Jianjiong Li
Ningbo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Fruquintinib Plus TAS-102 With or Without SBRT as Third- Or Later-Line Therapy for Metastatic Colorectal Cancer: Preliminary Results From a Prospective Phase II Trial.
Journal: Cancer medicine
Published: November 03, 2025
RAS mutations and colorectal cancer metabolism: a metabolomic analysis of tissue samples.
Journal: BMC cancer
Published: June 14, 2025
Considerations on taE-ISR versus cISR in rectal cancer surgery.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 18, 2025
Fruquintinib in metastatic colorectal cancer: a multicenter real-world analysis on efficacy, safety, and predictive and prognostic factors.
Journal: Journal of gastrointestinal oncology
Published: July 22, 2024
Fruquintinib for refractory colorectal cancer in a pre-treated 82-year-old patient achieved a progression-free survival of 25 months: a case report.
Journal: Journal of gastrointestinal oncology
Published: August 12, 2022
Prognostic signatures and potential pathogenesis of eRNAs-related genes in colon adenocarcinoma.
Journal: Molecular carcinogenesis
Published: June 03, 2021
Regulatory Network Analysis of Mutated Genes Based on Multi-Omics Data Reveals the Exclusive Features in Tumor Immune Microenvironment Between Left-Sided and Right-Sided Colon Cancer.
Journal: Frontiers in oncology
Published: March 25, 2021
Telomere in colorectal cancer associated with distant metastases and predicted a poor prognosis.
Journal: Translational cancer research
Published: November 29, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026